SISrinivasan Iyer

Srinivasan Iyer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Srinivasan Iyer has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Profiling risk factors for chronic uveitis in juvenile idiopathic arthritis: a new model for EHR-based research

    by Tyler S Cole, Jennifer Frankovich, Srinivasan Iyer, Paea LePendu, Anna Bauer-Mehren, Nigam H Shah

    Juvenile idiopathic arthritis is the most common rheumatic disease in children. Chronic uveitis is a common and serious comorbid condition of juvenile idiopathic arthritis, with insidious presentation and potential to cause blindness. Knowledge of clinical associations will improve risk stratification. Based on clinical observation, we hypothesized that allergic conditions are associated with chronic uveitis in juvenile idiopathic arthritis patients.


  • Open Access

    Annotation Analysis for Testing Drug Safety Signals using Unstructured Clinical Notes

    by Paea LePendu, Srinivasan V Iyer, Cédrick Fairon, Nigam H Shah

    Background: The electronic surveillance for adverse drug events is largely based upon the analysis of coded data from reporting systems. Yet, the vast majority of electronic health data lies embedded within the free text of clinical notes and is not gathered into centralized repositories. With the increasing access to large volumes of electronic medical data—in particular the clinical notes—it may be possible to computationally encode and to test drug safety signals in an active manner. Results: We describe the application of simple annotation tools on clinical text and the mining of the resulting annotations to compute the risk of getting a myocardial infarction for patients with rheumatoid arthritis that take Vioxx. Our analysis clearly reveals elevated risks for myocardial infarction in rheumatoid arthritis patients taking Vioxx (odds ratio 2.06) before 2005. Conclusions: Our results show that it is possible to apply annotation analysis methods for testing hypotheses about drug safety using electronic medical records.